anti anginal drugs
TRANSCRIPT
![Page 1: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/1.jpg)
ANTI-ANGINAL DRUGS
PROF.VINOD BHARDWAJ
![Page 2: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/2.jpg)
ANTI-ANGINAL DRUGS• ANTI-ANGINAL DRUGS • ANGINA PECTORIS:- IS A PAIN SYNDROME DUE TO INDUCTION OF AN
ADVERSE OXYGEN SUPPLY/DEMAND SITUATION IN A PORTION OF THE MYOCARDIUM.(FIG)
• TWO PRINCIPAL FORMS ARE RECOGNIZED: • A). CLASSICAL ANGINA (COMMON FORM):ATTACKS ARE
PREDICATABLY (STABLE ANGINA) PROVOKED BY EXERCISE, EMOTION, EATING OR COITUS AND SUBSIDE WHEN THE INCREASED ENERGY DEMAND IS WITHDRAWN. THE UNDERLYING PATHOLOGY IS SEVERE ARTERIOSCLEROTIC AFFLICTION OF LARGER CORONARY ARTERIES (CONDUCTING VESSELS) WHICH RUN EPICARDIALLY AND SEND PER FORATING BRANCHES TO SUPPLY THE DEEPER TISSUE.
![Page 3: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/3.jpg)
ANTI-ANGINAL DRUGS• THE CORONARY OBSTRUCTION IS FIXED; BLOOD FLOW
FAILS TO INCREASE DURING INCREASED DEMAND DESPITE LOCAL FACTORS MEDIATED DILATATION OF RESISTANCE VESSELS AND ISCHAEMIC PAIN IS FELT.
• DUE TO INADEQUACY OF ISCHAEMIC LEFT VENTRICLE, THE END DIASTOLIC LEFT VENTRICULAR PRESSURE RISES FROM 5 TO ABOUT 25 mmHg -> PRODUCES SUBENDOCARDIAL ‘CRUNCH’ DURING DIASTOLE (BLOOD FLOW TO THE SUBENDOCARDIAL REGION OCCURS ONLY DURING DIASTOLE) AND AGGRAVATES ISCHAEMIA IN THIS REGION.(FIG.)
![Page 4: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/4.jpg)
![Page 5: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/5.jpg)
ANTI-ANGINAL DRUGS
• DRUGS THAT ARE USEFUL, PRIMARILY REDUCE CARDIAC WORK (DIRECTLY BY ACTING ON HEART OR INDIRECTLY BY REDUCING PRELOAD HENCE, END DIASTOLIC PRESSURE, AND AFTERLOAD.
• THEY MAY ALSO CAUSE FAVOURABLE REDISTRIBUTION OF BLOOD FLOW TO THE ISCHAEMIC AREAS.
![Page 6: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/6.jpg)
ANTI-ANGINAL DRUGS• B). VARIANT / PRIZMETAL’S/UNSTABLE ANGINA
(UNCOMMON FORM):• ATTACKS OCCUR AT REST OR DURING SLEEP AND ARE
UNPREDICATABLE & ARE DUE TO RECURRENT LOCALIZED (OCCASIONALLY DIFFUSE) CORONARY VASOSPASM WHICH MAY BE SUPERIMPOSED ON ARTERIOSCLEROTIC CORONARY ARTERY DISEASE. ABNORMALLY REACTIVE AND HYPERTROPHIED SEGMENTS IN THE CORONARY ARTERIES HAVE BEEN DEMONSTRATED. DRUGS ARE AIMED AT PREVENTING AND RELIEVING THE CORONARY VASOPASM.
![Page 7: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/7.jpg)
![Page 8: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/8.jpg)
ANTI-ANGINAL DRUGS• UNSTABLE ANGINA WITH RAPID INCREASE IN
DURATION AND SEVERITY OF ATTACKS IS MOSTLY DUE TO RUPTURE OF AN ATHEROMATOUS PLAQUE, ATTRACTING PLATELET DEPOSITION AND PROGRESSIVE OCCLUSION OF THE CORONARY ARTERY; OCCASIONALLY WITH ASSOCIATED CORONARY VASOSPASM.
• ANTIANGIAL DURGS RELIEVE CARDIAC ISCHAEMIA BUT DO NOT ALTER THE COURSE OF CORONARY ARTERY PATHOLOGY, HENCE, NO PERMANENT BENEFIT IS AFFORDED.
![Page 9: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/9.jpg)
ANTI-ANGINAL DRUGS• CLASSIFICATION OF ANTI-ANGINAL DRUGS:• 1. NITRATES OR NITROVSODILATORS:
(A). SHORT ACTING:-- GLYCERYL TRINITRATE (GTN, NITROGLYCERINE)(B). LONG ACTING:-
- ISOSORBIDE DINITRATE (SHORT ACTING BY SUBLINGUAL ROUTE),
- ISOSORBIDE MONONITRATE, - ERYTHRITYL TETRANITRATE, - PENTA ERYTHRITOL TETRAINTRATE.
![Page 10: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/10.jpg)
ANTI-ANGINAL DRUGS2. ΒETA - BLOCKERS:• - PROPRANOLOL, • - METOPROLOL,• - ATENOLOL
3. CALCIUM CHANNEL BLOCKERS:(a). PHENYLALKYLAMINE:• - VERAPAMIL. (b). BENZOTHIAZEPINES:• - DILTIAZEM( c ). DIHYDROPYRIDINES:• - NIFEDIPINE,• - FELODIPINE,• - AMLODIPINE,• - NITRENDIPINE,• - LACIDIPINE,• - BENIDIPINE,• - LERCANIDIPINE
![Page 11: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/11.jpg)
ANTI-ANGINAL DRUGS4. POTASSIUM CHANNEL OPENER:
- NICORANDIL 5. MISCELLANEOUS DRUGS:
- DIPYRIDAMOLE, - RANOLAZINE- TRIMETAZIDINE. - OXYPHEDRINE
CLINICAL CLASSIFICATION OF ANTI-ANGINAL DRUGS:• A. DRUG USED SUBLINGUALLY TO ABORT OR TERMINATE
AN ACUTE ATTACK: - GTN (SUBLINGUALLY)- ISOSORBIDE DINITRATE (SUBLINGUALLY).
• B. USED FOR CHRONIC PROPHYLAXIS: ALL OTHER DRUGS GIVEN ORALLY.
![Page 12: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/12.jpg)
ANTI-ANGINAL DRUGSNITROVASODILATORS: THESE AGENTS ARE PRODRUGS THAT ARE SOURCES OF NITRIC OXIDE (NO). NO ACTIVATES THE SOLUBLE ISOFORM OF GUANYLYL CYCLASE, THEREBY INCREASING INTRACELLULAR LEVELS OF CYCLIC GMP. IN TURN, THIS PROMOTES THE DEPHOSPHORYLATION OF THE MYOSIN LIGHT CHAIN AND THE REDUCTION OF CYSTOLIC (Ca2+) AND LEADS TO THE RELAXATION OF SMOOTH MUSCLE CELLS IN A BROAD RANGE OF TISSUES.
• THE NO-DEPENDENT RELAXATION OF VASCULAR SMOOTH MUSCLE LEADS TO VASODILATION. NO-MEDIATED GUANYLYL CYCLASE ACTIVATION INHIBITS PLATELET AGGREGATION AND ALSO RELAXES SMOOTH MUSCLE IN THE BRONCHI AND GASTROINTESTINAL (GI) TRACT .
![Page 13: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/13.jpg)
ANTI-ANGINAL DRUGS• THE BROAD BIOLOGICAL RESPONSE TO NITROVASODILATORS
SUGGESTS THE EXISTENCE OF ENDOGENOUS NO-MODULATED REGULATORY PATHWAYS;
• MORE THAN A CENTURY AFTER THE THERAPEUTIC USE OF NITROVASODILATORS, THE ENZYMES RESPONSIBLE FOR ENDOGENOUS NO SYNTHESIS WERE ISOLATED AND CHARACTERIZED. THE ENDOGENOUS SYNTHESIS OF NO IN HUMANS IS CATALYZED BY A FAMILY OF NO SYNTHASES THAT OXIDIZE THE AMINO ACID L-ARGININE TO FORM NO.
• THERE ARE THREE DISTINCT MAMMALIAN NO SYNTHASE ENZYME ISOFORMS TERMED NNOS, ENOS, AND INOS , AND THEY ARE INVOLVED IN PROCESSES AS DIVERSE AS NEUROTRANSMISSION, VASOMOTION, AND IMMUNOMODULATION. IN SEVERAL VASCULAR DISEASE STATES, PATHWAYS OF ENDOGENOUS NO-DEPENDENT REGULATION APPEAR TO BE DERRANGED.
![Page 14: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/14.jpg)
ANTI-ANGINAL DRUGS
NITRATES (GTN AS PROTOTYPE):• ALL ORGANIC NITRATES SHARE THE
SAME ACTION; DIFFER ONLY IN TIME COURSE. THE ONLY MAJOR ACTION IS DIRECT NONSPECIFIC SMOOTH MUSCLE RELAXATION.
![Page 15: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/15.jpg)
ANTI-ANGINAL DRUGS
• THE MOST PROMINENT ACTION IS EXERTED ON VASCULAR SMOOTH MUSCLE.
• NITRATES DILATE VEINS MORE THAN ARTERIES - > PERIPHERAL POOLING OF BLOOD - > DECREASED VENOUS RETURN - > PRELOAD ON HEART IS REDUCED - > END DIASTOLIC VOLUME & VENTRICULAR SIZE & PRESSURE ARE REDUCED - > DECREASED CARDIAC WORK - > DECREASED OXYGEN DEMAND.
![Page 16: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/16.jpg)
ANTI-ANGINAL DRUGS
• THE DECREASE IN END DIASTOLIC PRESSURE ABOLISHES THE SUBENDOCARDIAL CRUNCH BY RESTORING THE PRESSURE GRADIENT ACROSS VENTRICULAR WALL DUE TO WHICH SUBENDOCARDIAL PERFUSION OCCURS DURING DIASTOLE.
• IT IS THROUGH THIS ACTION ON PERIPHERAL VEINS THAT NITRATES EXERT MAJOR BENEFICIAL EFFECTS IN CLASSICAL ANGINA.
![Page 17: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/17.jpg)
ANTI-ANGINAL DRUGS
• NITRATES ALSO PRODUCE SOME ARTERIOLAR DILATATION -> SLIGHTLY DECREASE TOTAL PERIPHERAL RESISTANCE (T.P.R.) OR AFTERLOAD ON HEART - > BP FALLS SOMEWHAT, SYSTOLIC MORE THAN DIASTOLIC (REFLEX SYMPATHETIC ACTIVITY TENDS TO MAINTAIN DIASTOLIC BP).
• THIS ACTION CONTRIBUTES TO THE REDUCTION OF CARDIAC WORK WHICH IS DIRECTLY PROPORTIONAL TO AORTIC IMPEDANCE.
![Page 18: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/18.jpg)
ANTI-ANGINAL DRUGS
• IN THE ARTERIAL TREE, NITRATES PREFERENTIALLY RELAX BIGGER CONDUCTING (ANGIOGRAPHICALLY VISIBLE) CORONARY ARTERIES THAN ARTERIOLES OR RESISTANCE VESSELS WITHOUT AFFECTING THE AUTOREGULATORY VASODILATATION IN THE SUBENDOCARDIAL ISCHEMIC ZONE.
![Page 19: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/19.jpg)
ANTI-ANGINAL DRUGS• THIS PATTERN OF ACTION MAY CAUSE FAVORABLE
REDISTRIBUTION OF BLOOD FLOW TO ISCHAEMIC AREAS IN ANGINA PATIENTS. DILATATION OF CONDUCTING VESSELS ALL OVER BY NITRATE ALONG WITH ISCHAEMIA INDUCED DILATATION OF AUTOREGULATORY RESISTANCE VESSELS ONLY IN THE ISCHAEMIC ZONE INCREASES BLOOD FLOW TO THIS AREA; WHILE IN THE NON –ISCHAEMIC ZONES, RESISTANCE VESSELS MAINTAIN THEIR TONE & BLOOD FLOW DOES NOT INCREASE, RATHER, MAY DECREASE TO COMPENSATE FOR INCREASED FLOW TO ISCHAEMIC ZONE.
• IN FACT, NITRATES DO NOT APPRECIABLY INCREASE TOTAL CORONARY FLOW IN ANGINA PATIENTS.
![Page 20: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/20.jpg)
ANTI-ANGINAL DRUGS• THE DILATOR EFFECT ON LARGER CORONARY VESSELS
IS THE PRINCIPAL ACTION OF NITRATES BENEFITING VARIANT ANGINA BY COUNTER ACTING CORONARY SPASM.
• IN CLASSICAL ANGINA, UNDOUBTEDLY, THE PRIMARY ACTION IS TO REDUCE CARDIAC WORK BY ACTION ON PERIPHERAL VASCULATURE, THOUGH INCREASED BLOOD SUPPLY TO ISCHAEMIC AREA MAY CONTRIBUTE.
• EXERCISE TOLERANCE OF ANGINA PATIENTS IS INCREASED BECAUSE THE SAME AMOUNT OF EXERCISE CAUSE LESSER AUGMENTATION OF CARDIAC WORK.
![Page 21: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/21.jpg)
ANTI-ANGINAL DRUGS• NITRATES HAVE NO DIRECT STIMULANT OR
DEPRESSANT ACTION ON HEART. THEY DILATE CUTANEOUS ARTERIOLES (ESPECIALLY OVER FACE AND NECK - > FLUSHING) AND MENINGEAL VESSELS -> HEADACHE.
• SPLANCHNIC & RENAL BLOOD FLOW DECREASES TO COMPENSATE FOR VASODILATATION IN OTHER AREAS. THEY TEND TO DECONGEST LUNGS BY SHIFTING BLOOD TO SYSTEMIC CIRCULATION.
• BRONCHI, BILIARY TRACT AND ESOPHAGUS ARE RELAXED; EFFECT ON INTESTINE, URETER AND UTERUS IN VARIABLE AND INSIGNIFICANT.
![Page 22: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/22.jpg)
ANTI-ANGINAL DRUGS• MOLECULAR MECHANISM OF ACTION OF
NITROVASODILATORS:• ORGANIC NITRATES ARE RAPIDLY DENITRATED
ENZYMATICALLY ( BY NO SYNTHEASES) IN THE SMOOTH MUSCLE CELL TO RELEASE THE REACTIVE FREE RADICAL NITRIC OXIDE (NO) WHICH ACTIVATES CYTOSOLIC GUANYLYL CYCLASE - > INCREASED C-GMP CAUSES DEPHOSPHORYLATION OF MYOSIN LIGHT CHAIN KINASE (MLCK) THROUGH A C-GMP-DEPENDENT PROTEIN KINASE (FIG. 11.4).
![Page 23: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/23.jpg)
![Page 24: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/24.jpg)
ANTI-ANGINAL DRUGS
• REDUCED AVAILABILITY OF PHOSPHORYLATED (ACTIVE) MLCK INTERFERES WITH ACTIVATION OF MYOSIN IT FAILS TO INTERACT WITH ACTIN TO CAUSE CONTRACTION. CONSEQUENTLY, RELAXATION OCCURS. RAISED INTRACELLULAR C-GMP MAY ALSO REDUCE Ca2+ ENTRY -> CONTRIBUTING TO RELAXATION.
![Page 25: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/25.jpg)
ANTI-ANGINAL DRUGS
• PHARMACOKINETICS:• ORGANIC NITRATES ARE LIPID SOLUBLE WELL
ABSORBED FROM BUCCAL MUCOSA, INTESTINES AND SKIN.
• ALL EXCEPT ISOSORBIDE MONONITRATE UNDERGO EXTENSIVE BUT VARIABLE FIRST PASS METABOLISM IN LIVER.
• THEY ARE RAPIDLY DENITRATED BY A GLUTATHIONE REDUCTASE.
![Page 26: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/26.jpg)
ANTI-ANGINAL DRUGS• ADVERSE EFFECTS: THESE ARE MOSTLY DUE TO
VASODILATATION. • FULLNESS IN HEAD, THROBBING HEADACHE; SOME
DEGREE OF TOLERANCE DEVELOPS ON CONTINUED USE.
• FLUSHING, WEAKNESS, SWEATING, PALPITATION, DIZZINESS AND FAINTING; THESE ARE MITIGATED BY LYING DOWN AND ACCENTUATED BY ERECT POSTURE AND ALCOHOL.
• METHEMOGLOBINEMIA: IS NOT MARKED WITH CLINICALLY USED DOSES.
• RASHES ARE RARE.
![Page 27: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/27.jpg)
ANTI-ANGINAL DRUGS• TOLERANCE ATTENUATION OF HAEMODYNAMIC AND
ANTIISCHAEMIC EFFECT OF NITRATES OCCURS IF THEY ARE CONTINUOUSLY PRESENT IN THE BODY.
• THIS TOLERANCE WEANS OFF RAPIDLY (WITHIN HOURS)WHEN THE BODY IS FREE OF THE DRUG. CLINICALLY, NO SIGNIFICANT TOLERANCE DEVELOPS ON INTERMITTENT USE OF SUBLINGUAL GTN FOR ATTACKS OF ANGINA. HOWEVER, IT MAY BECOME IMPORTANT WHEN GTN IS USED ORALLY, TRANSDERMALLY OR BY CONTINUOUS I.V. INFUSION ROUND THE CLOCK.
![Page 28: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/28.jpg)
ANTI-ANGINAL DRUGS
• THE MOST PRACTICAL WAY TO PREVENT NITRATE TOLERANCE IS TO PROVIDE NITRATE FREE INTERVALS EVERY DAY.
• SILDENAFIL CAUSES DANGEROUS POTENTIATION OF NITRATE ACTION: SEVERE HYPOTENSION, MI AND DEATHS ARE ON RECORD.
• ADDITIVE HYPOTENSION, IS ALSO POSSIBLE WHEN NITRATE IS GIVEN TO PATIENT RECEIVING OTHER VASODILATORS.
![Page 29: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/29.jpg)
ANTI-ANGINAL DRUGSINDIVIDUAL COMPOUNDS: • 1.GLYCERYL TRINITRATE: IT IS A VOLATILE LIQUID WHICH IS
ABSORBED ON THE INERT MATRIX OF TABLET. THE SUBLINGUAL ROUTE IS USED WHEN TERMINATING AN ATTACK OR ABORTING AN IMMINENT ONE IS THE AIM. IT ACTS WITHIN 1-2MIN (PEAK BLOOD LEVEL IN 3-6MIN) BECAUSE OF DIRECT ABSORPTION INTO SYSTEMIC CIRCULATION (BYPASSING LIVER WHERE ALMOST 90% IS METABOLIZED).
• PLASMA t1/2 IS 2 MIN, DURATION OF ACTION DEPENDS ON THE PERIOD IT REMAINS AVAILABLE FOR ABSORPTION FROM BUCCAL MUCOSA.
• THE REMAINING PART OF THE TABLET MAY BE SPIT OR SWALLOWED WHEN NO LONGER NEEDED.
![Page 30: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/30.jpg)
ANTI-ANGINAL DRUGS• SUSTAINED RELEASE ORAL CAPSULES CONTAINING
MUCH LARGER AMOUNTS OF GTN CAN BE USED FOR CHRONIC PROPHYLAXIS.
• NITROGLYCERINE IS READILY ABSORBED FROM THE SKIN. A TRANSDERMAL PATCH IN WHICH THE DRUG IS INCORPORATED INTO A POLYMER BONDED TO ADHESIVE PLASTER HAS BEEN DEVELOPED WHICH PROVIDES STEADY DELIVERY FOR 24 HOURS. HOWEVER, DEVELOPMENT OF TOLERANCE AND DEPENDENCE MAY JEOPARDIZE ITS VALUE. IT IS ADVISED THAT THE PATCH BE TAKEN OFF FOR 8 HOURS DAILY.
![Page 31: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/31.jpg)
ANTI-ANGINAL DRUGS
• INTRAVENOUS INFUSION OF GTN PROVIDES RAPID, STEADY, TITRATABLE PLASMA CONCENTRATION FOR AS LONG AS DESIRED.
• IT HAS BEEN SUCCESSFULLY USED FOR : - UNSTABLE ANGINA,- CORONARY VASOPASM, - LVF ACCOMPANYING MI, - HYPERTESION DURING CARDIAC
SURGERY, ETC.
![Page 32: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/32.jpg)
ANTI-ANGINAL DRUGS
• 2.ISOSORBIDE DINITRATE :• IT CAN BE USED SUBLINGUALLY AT THE TIME
OF ATTACK (SLIGHTLY SLOWER IN ACTION THAT GTN, PEAK IN 5-8 MIN)
• USED ORALLY FOR CHRONIC PROPHYLAXIS. THE t 1/2 IS 40 MIN, BUT SUSTAINED RELEASE FORMULATION MAY AFFORD PROTECTION FOR 6-10 HOURS.
![Page 33: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/33.jpg)
ANTI-ANGINAL DRUGS• 3.ISOSORBIDE MONONITRATE : • THIS IS AN ACTIVE METABOLITE OF ISOSORBIDE
DINITRATE. WHEN ADMINISTERED ORALLY, IT UNDERGOES LITTLE FIRST PASS METABOLISM.
• BIOAVAILABILITY IS HIGH, INTERINDIVIDUAL DIFFERENCES ARE MINIMAL AND IT IS LONGER ACTING (t1/2 4-6 HR).4. ERYTHRITYL TETRANITRATE, 5. PENTA ERYTHRITOL TETRAINTRATE.THESE ARE LONGER ACTING NITRATES USED ONLY FOR CHRONIC PROPHYLAXIS.
![Page 34: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/34.jpg)
ANTI-ANGINAL DRUGSTHERAPEUTIC USES OF NITROVASODILATORS:1.ANGINA PECTORIS: NITRATES ARE EFFECTIVE IN CLASSICAL AS WELL AS
VARIANT ANGINA.- FOR ABORTING OR TERMINATING AN ATTACK, SUBLINGUAL GTN TABLET OR ISOSORBIDE DINITRATE IS TAKEN ON ‘AS AND WHEN REQUIRED’ BASIS. - SINCE DENTAL PROCEDURES ARE OFTEN AN EMOTIONAL STRESS, ANGINAL ATTACK MAY BE PRECIPITATED. SUBLINGUAL GTN TABLET SHOULD BE READILY AVAILABLE TO ABORT/TERMINATE SUCH AN ATTACK ON THE DENTAL CHAIR. - NITRATES INCREASE EXERCISE TOLERANCE AND POSTPONE ECG CHANGES OF ISCHAEMIA. - LONGER ACTING FORMULATIONS (ORAL, TRANSDERMAL) OF GTN OR OTHER NITRATES ARE USED ON REGULAR SCHEDULE FOR CHRONIC PROPHYLAXIS. NITRATES ARE EFFECTIVE IN UNSTABLE ANGINA AS WELL. HOWEVER, ANTIPLATELET DRUGS ARE THE PRIMARY MEASURE IN UNSTABLE ANGINA.
![Page 35: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/35.jpg)
ANTI-ANGINAL DRUGS
2. IN ACUTE CORONARY SYNDROMES: THESE ARE CHARACTRIZED BY RAPIDLY WORSENING CARDIAC STATUS OF THE PATIENT BY CONDITIONS SUCHAS UNSTABLE ANGINA AND NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (NSTEMI).THESE NECESSITATE AGGRESSIVE & EFFECTIVE THERAPY TO PREVENT FURTHER CORONARY OCCLUSION,INCREASE CORONARY BLOOD FLOW, AND DECREASE MYOCARDIAL STRESS BY DECREASING OXYGEN DEMAND.
![Page 36: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/36.jpg)
ANTI-ANGINAL DRUGS
• NITROVASODILATORS ARE EFFECTIVE BY:• - DECREASING PRE-LOAD (MYOCARDIAL
WORKLOAD IS DECREASED),• - INCREASING CORONARY BLOOD FLOW
(CORONARY VASODILATATION & REVERSAL OF CORONARY SPASM IF PRESENT),
• - DECREASING MYOCARDIAL STRESS BY DECREASING ITS OXYGEN DEMAND.
![Page 37: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/37.jpg)
ANTI-ANGINAL DRUGS• INITIALLY GTN IS GIVEN SUBLINGUALLY, BUT IF PAIN PERSISTS
AFTER THREE TABLETS AT 5 MIN. INTERVALS , I.V INFUSION OF GTN IS STARTED.
• THE ROLE OF NITRATES IS HOWEVER LIMITED TO CONTROL OF PAIN, BECAUSE NO BENEFIT IS DISCOVERED IN DECREASING MORTALITY OR MORBIDITY.
• ANTIPLATELET DRUGS LIKE ASPIRIN, CLOPIDOGREL, GPIIb/IIIa RECEPTOR ANTAGONISTS AND HEPARIN AND A BETA BLOCKER ARE THE PRIMARY MEASURES IN THESE CONDITIONS.
• OTHER MEASURES IN UNSTABLE ANGINA ARE THROMBOLYTICS, CORONARY ANGIOPLASTY WITH STENTS CARRYING SUITABLE DRUGS AND CORONARY BYPASS SURGERY
![Page 38: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/38.jpg)
ANTI-ANGINAL DRUGS• 3. MYOCARDIAL INFARCTION: ADMINISTRATION OF
CAREFULLY TITRATED I.V. INFUSION OF GTN, WITHOUT CAUSING HYPOTENSION & TACHYCARDIA, IS FREQUETLY USED IN A PATIENT OF EVOLVING ACUTE M.I. BECAUSE SUCH A PATIENT IS BENEFITED BY:
• - THE RELIEF OF THE ISCHEMIC PAIN,• - DECREASE IN PULMONARY CONGESTION,• - LIMITING THE AREA OF NECROSIS BY FAVORABLY
ALTERING THE OXYGEN BALANCE IN THE MARGINAL PARTIALLY ISCHEMIC ZONE OF MYOCARDIUM, AS A CONSEQUENCE OF PRELOAD REDUCTION.
![Page 39: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/39.jpg)
ANTI-ANGINAL DRUGS• NITRATES AFFORD RELIEF BY VENOUS POOLING OF BLOOD
REDUCED VENOUS RETURN (PRELOAD) DECREASED END DIASTOLIC VOLUME AND LEFT VENTRICULAR WALL TENSION IMPROVEMENT IN LEFT VENTRICULAR FUNCTION.
• INTRAVENOUS GTN IS THE PREPARATION OF CHOICE FOR EMERGENCY USE, BUT THE RATE OF INFUSION MUST BE GUIDED BY CONTINUOUS HAEMODYNAMIC MONITORING TO AVOID HYPOTENSION & TACHYCARDIA.
• THE ECG SIGNS, ARRHYTHMIAS AND EARLY MORTALITY MAY ALSO BE REDUCED. NITRATE THERAPY IN THE POST INFARCTION PERIOD DOES NOT ALTER MORTALITY, BUT IT CAN BE USED FOR RELIEF OF ANGINA.
![Page 40: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/40.jpg)
ANTI-ANGINAL DRUGS• PROPER PATIENT SELECTION IS IMPORTANT, GTN
SHOULD NOT BE ADMINISTRERED IF:• - SYSTOLIC B.P. IS < 90 mm Hg.• - H.R IS <50 OR >100 min.• - RIGHT VENTRICULAR INFARCTION IS SUSPECTED,• - HYPOTENSION CAUSED BY GTN LIMITS THE USE
OF BETA BLOCKER WHICH HAS MORE BENEFICIAL & SALUTARY RESULTS THAN GTN.
• - PATIENT HAS TAKEN SILDENEFIL IN PAST 24 HRS.
![Page 41: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/41.jpg)
ANTI-ANGINAL DRUGS4. IN C.H.F & ACUTE L.V.F:
NITRATES AFFORD RELIEF IN SUCH PATIENTS BY VENOUS POOLING OF BLOOD, WHICH CAN BE ACCENTUATING BY SITTING THE PATIENT IN PROPPED UP POSITION -> REDUCED VENOUS RETURN -> DECREASED END-DIASTOLIC VOLUME AND LEFT VENTRICULAR WALL TENSION -> IMPROVEMENT OF LEFT VENTRICULAR FUNCTION BY LAPLACE LAW & DECREASE IN PULMONARY CONGESTION.- I.V. GTN IS A DRUG OF CHOICE IN THESE PATIENTS BUT NEEDS CAREFUL HEMODYNAMIC MONITORING & CONTROL OF THE RATE OF I.V. INFUSION.
![Page 42: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/42.jpg)
ANTI-ANGINAL DRUGS
5. BILIARY COLIC: SUBLINGUAL GTN OR ISOSORBIDE DINITRATE EFFECTIVELY COUNTERS THE BILIARY SPASM INDUCED BY OPIOIDS OR DISEASE STATES.
6. ESOPHAGEAL SPASM: SUBLINGUAL GTN PROMPTLY RELIEVES PAIN. NITRATES TAKEN BEFORE MEALS FACILITATE FEEDING IN ESOPHAGEAL ACHALASIA BY REDUCING ESOPHAGEAL TONE.
![Page 43: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/43.jpg)
ANTI-ANGINAL7. CYANIDE POISONING: NITRATES GENERATE
METHAEMOGLOBIN WHICH HAS HIGH AFFINITY FOR CYANIDE RADICAL AND FORMS CYANOMETHAEMOGLOBIN. CYTOCHROME AND OTHER OXIDATIVE ENZYMES ARE THUS PROTECTED FROM CYANIDE. HOWEVER, CYNAMTHEMOGLOBIN MAY AGAIN DISSOCIATE TO FORM CYANIDE, THEREFORE SODIUM THIOSULFATE IS GIVEN TO FORM SOD. THIOCYANATE WHICH IS POORLY DISSOCIABLE AND IS ECRETED IN URINE. AN EARLY TREATMENT IS NECESSARY & THE ANTIDOTES SHOULD BE REPEATED AS NEEDED.
![Page 44: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/44.jpg)
ANTI-ANGINAL• HEMOGLOBIN• SODIUM NITRITE ( 10 ml.OF 3%
SOLUTION, I.V.)• METHEMOGLOBIN• CYANIDE• CYNOMTHEMOGLOBIN• SOD. THIOSULPHATE(50ml. OF
25% SOLUTION, I.V.)• METHEMOGLOBIN + SOD. THIOCYANATE
(EXCRTETED IN URINE)
![Page 45: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/45.jpg)
ANTI-ANGINAL• ΒETA BLOCKERS:• THESE DRUGS DO NOT DILATE CORONARIES OR OTHER BLOOD
VESSELS; TOTAL CORONARY FLOW IS RATHER REDUCED DUE TO BLOCKADE OF DILATOR Β2- RECEPTORS. HOWEVER, FLOW TO THE ISCHAEMIC SUBENDOCARDIAL AREA IS NOT REDUCED BECAUSE OF FAVOURABLE REDISTRIBUTION AND DECREASE IN VENTRICULAR WALL TENSION.
• THEY ACT BY:- REDUCING CARDIAC WORK AND- O2 CONSUMPTION (DECREASED HEART RATE, INOTROPIC STATE AND MEAN BP). THIS IS MARGINAL AT REST. MORE IMPORTANTLY, THEY LIMIT INCREASE IN THESE MODALITIES THAT OCCURS DURING EXERCISE OR ANXIETY (DUE TO ANTIADRENEGIC ACTION ON HEART).
![Page 46: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/46.jpg)
ANTI-ANGINAL• ALL ΒETA BLOCKERS ARE NEARLY EQUALLY EFFECTIVE IN
DECREASING FREQUENCY AND SEVERITY OF ATTACKS AND INCREASING EXERCISE TOLERANCE IN CLASSICAL ANGINA.
• CARDIOSELECTIVE AGENTS (ATENOLOL & METOPROLOL) ARE PREFERRED OVER NONSELECTIVE Β1 + Β2 BLOCKERS (PROPRANOLOL) WHICH MAY WORSEN VARIANT ANGINA.
• LONG –TERM Β BLOCKER THERAPY LOWERS RISK OF SUDDEN CARDIAC DEATH AMONG ISCHAEMIC HEART DISEASE PATIENTS. ΒETA - BLOCKERS ARE TO BE TAKEN ON A REGULAR SCHEDULE; NOT ON ‘AS AND WHEN REQUIRED’ BASIS.THE DOSE HAS TO BE INDIVIDUALIZED. ABRUPT WITHDRAWAL AFTER CHRONIC USE MAY PRECIPITATE SEVERE ATTACKS, EVEN M.I.
![Page 47: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/47.jpg)
ANTI-ANGINAL
• IN UNSTABLE ANGINA & NON ST-ELEVATION M.I: THE BETA BLOCKERS ARE ROUTINELY EMPLOYED UNLESS CONTRAINDICATED. HOWEVER, SHOULD BE ADMINISTERED ONLY AFTER STARTING NITRATE WITH OR WITHOUT Ca++ CHANNEL BLOCKER TO COUNTERACT ANY CORONARY VASOSPASM INDUCED BY BETA BLOCKER, WHICH MAY WORSEN THE UNSTABLE ANGINA.
![Page 48: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/48.jpg)
ANTI-ANGINAL
• BETA BLOCKERS REDUCE MYOCARDIAL OXYGEN DEMAND AND AFFORD ADDITIONAL BENEFIT BY REDUCING THE RISK OF IMPENDING M.I AND OR SUDDEN CARDIAC DEATH.
![Page 49: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/49.jpg)
ANTI-ANGINAL
• CALCIUM CHANNEL BLOCKERS: VERAPAMIL WAS THE FIRST DRUG OF THIS GROUP TO BE DEVELOPED, WHICH ACTS BY BLOCKING THE Ca++ ION CHANELS. A LARGE NUMBER OF CHEMICALLY DIVERSE Ca++ CH. BLOCKERS HAVE BEEN DEVELOPED WHICH CAN BE PUT INTO THREE CLASSES:
• I. PHENYLALKYLAMINES: e.g. VERAPAMIL(HYDROPHILIC).• II. DIHYDROPYRIDINES: e.g., NIFEDEPINE (LIPOPHILIC).• III. BENZOTHIAZEPINES: e.g., DILTIAZEM (HYDROPHILIC).• THE DIHYDROPYRIDINES (DHPs) ARE THE MOST POTENT
OF ALL THE Ca++ CH. BLOCKERS.
![Page 50: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/50.jpg)
ANTI-ANGINAL• CALCIUM CHANNELS: THREE TYPES OF CALCIUM CHANNELS ARE
PRESENT IN SMOOTH MM AND OTHER EXCITABLE CELLS:• I. VOLTAGE SENSITIVE Ca++ CHANNELS.• II. RECEPTOR OPERATED Ca++ CHANNELS.• III. LEAK CHANNELS.• THE VOLTAGE SENSITIVE Ca++ CHANNELS ARE HETEROGENOUS
AND THREE MAJOR SUBTYPES ARE KNOWN : L-TYPE, T-TYPE AND N-TYPE. EVEN THE SMOOTH MM. L-TYPE CHANNELS DIFFER AS THE VASCULAR AND NONVASCULAR TYPES, AND THEIR DISTRIBUTION MAY BE HETEROGENOUS IN DIFFERENET PART OF THE VASCULAR BED. THE L-TYPE Ca++ CHANNELS ARE SO NAMED BECAUSE THEY ARE SENSITIVE TO LONG LASTING CURRENT.
![Page 51: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/51.jpg)
ANTI-ANGINAL• ONLY THE VOLTAGE SENSITIVE L-TYPE Ca++ CHANNELS
ARE BLOCKED BY THE THREE CLASSES OF THE Ca++ CHANNEL BLOCKERS.
• PHARMACOLOGICAL ACTIONS:• THE COMMON PROPERTY OF ALL THE THREE CLASSES OF
C.C.Bs. IS TO INHIBIT Ca++ MEDIATED SLOW CHANNEL COMPONENT OF THE ACTION POTENTIAL IN SMOOTH mm. AND CARDIAC mm. CELLS.
• THE TWO MOST IMPORTANT ACTIONS OF THE CCBs ARE:• I. SMOOTHN mm. RELAXATION (MAINLY VASCULAR)• II. NEGATIVE CHRONOTROPIC, INOTROPIC AND
DROMOTROPIC ACTION ON HEART.
![Page 52: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/52.jpg)
ANTI-ANGINAL
• ACTION ON SMOOTH mm.:• SMOOTH MUSCLES DEPOLARISE PRIMARILY BY
INWARD Ca++ ION MOVEMENT THROUGH VOLTAGE SENSITIVE Ca++ CHANNELS.
• THESE Ca++ IONS TRIGGER RELEASE OF MORE Ca+ IONS FROM SARCOPLASMIC RETICULUM AND INTRACELLULAR STORES AND TOGATHER BRING ABOUT EXCITATION-CONTRACTION COUPLING THROUGH PHOSPHORYLATION OF MYOSIN LIGHT CHAIN.
![Page 53: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/53.jpg)
ANTI-ANGINAL
• CCBs CAUSE SMOOTH MM RELAXATION BY DECREASING AVAILABILITY OF INTRACELLULAR FREE Ca++ IONS.
• CCBs MARKEDLY RELAX ARETERIOLES BUT HAVE ONLY MILD EFFECTS ON VEINS.
• EXTRAVASCULAR SMOOTH MM. OF BRONCHI, GIT, BILIARY, VESICAL AND UTERUS ARE ALSO RELAXED.
![Page 54: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/54.jpg)
ANTI-ANGINAL• THE DIHYDROPYRIDINES (NIFEDEPINE) HAVE THE
MOST MARKED SMOOTH MM. RELAXANT AND VASODILATOR ACTION.
• VERAPAMIL IS SOMEWHAT WEAKER, FOLLOWED BY DILTIAZEM.
• NITRENDEPINE AND OTHER DHPs ALSO HAVE A NITRIC OXIDE GENERATING ACTION ON ENDOTHELIUM AND AN ADDITIONAL INHIBITORY ACTION ON c-AMP-PDEase RESULTING IN INCREASED SMOOTH MM c-AMP PRODUCING THEIR PREDOMINANT SMOOTH MM RELAXANT ACTION. RELEASED NO MAY ALSO HAVE ANTIATHERSCLEROTIC ACTION.
![Page 55: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/55.jpg)
ANTI-ANGINAL
• ACTIONS ON HEART: NORMALLY, IN THE WORKING ATRIUM AND VENTRICLE FIBRES, Ca++ MOVES IN DURING THE PLATEAU PHASE OF ACTION POTNTIAL -> RELEASES MORE Ca++ FROM SARCOPLASMIC RETICULUM -> CONTRACTION OCCURS THROUGH BINDING TO TROPONIN -> ALLOWING INTERACTION OF ACTIN & MYOSIN.
• THE CCBs WOULD THUS HAVE A NEGATIVE INOTROPIC ACTION ON THE MYOCARDIUM.
![Page 56: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/56.jpg)
ANTI-ANGINAL• THE ‘0’- PHASE DEPOLARIZATION IN S.A. NODE &
A.V.NODE IS LARGELY Ca++ MEDIATED AND AUTOMATICITY & CONDUCTIVITY OF THESE CELLS APPEARS TO BE DEPENDENT ON THE RATE OF RECOVERY OF THE Ca++ CHANNELS.
• -…………………RECOVERY-------------------------------• RESTING -> ACTIVATED -> INACTIVATED CH.• NON- CONDUCTS NON-• CONDUCTING Ca++ CONDUCTING
![Page 57: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/57.jpg)
ANTI-ANGINAL• THE L-TYPE CHANNELS BOTH ACTIVATE AND
INACTIVATE SLOWLY. CONSEQUENTLY, Ca++ DEPOLARIZED CELLS (SA & AV NODE) HAVE A CONSIDERABLY LESS STEEP ‘0’ PHASE AND LONGER REFRACTORY PERIOD.
• THE RECOVERY PROCESS WHICH RESTORES THE CHANNEL TO THE FORM FROM WHICH IT CAN BE ACTIVATED AGAIN BY MEMBRANE DEPOLARIZATION IS DELAYED BY VERAPAMIL AND TO A LESSER EXTENT BY DILTIAZEM BUT NOT BY DHPs( THEY DO NOT PRODUCE NEGATIVE CHRONOTROPIC & DROMOTROPIC ACTIONS).
![Page 58: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/58.jpg)
ANTI-ANGINAL
• THE CHANNEL BLOCKADE PRODUCED BY VERAPAMIL IS ENHANCED AT HIGHER RATES OF STIMULATION, THAT BY NIFEDEPINE IS INDEPENDENT OF THIS FREQUENCY AND THAT BY DILTIAZEM IS INTERMEDIATE.
• VERAPAMIL AND ALSO DILTIAZEM, THUS PRODUCE SLOWING OF SINUS RATE AND AV CONDUCTION AND CAUSE BRADYCARDIA, NIFEDEPINE DOES NOT.
![Page 59: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/59.jpg)
ANTIANGINAL DRUGS
• THE RELATIVE POTENCIES OF THE THREE CLASSES OF CCBs TO BLOCK SMOOTH MM. SLOW CHANNELS ALSO DIFFERS AND DOES NOT PARRALEL HEART.
• DHPs ARE MORE SELECTIVE FOR SMOOTH MM L – CHANNELS AT CONCENTRATIONS WHICH CAUSE VASODILATATION, AND CAUSE NEGLIGIBLE NEGATIVE INOTROPIC ACTION.
• DILTIAZEM CAUSES LESS DEPRESSION OF CONTRACTILITY THAN VERAPAMIL.
![Page 60: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/60.jpg)
ANTI-ANGINAL• PHARMACOKINETICS: ALL CCBs ARE ABSORBED 90 – 100% ORALLY.• PEAK OCCURS AT 1 – 3 HRS EXCEPT AMLODEPINE WHICH IS SLOW ACTING
WITH PEAK AT 6 – 9 HRS.• ORAL BIOAVAILABILITY DIFFERS PRODUCING GREAT INTER AND INTRA
INDIVIDUAL VARIATIONS OWING TO HIGH FIRST PASS METABOLISM, EXCEPT IN THE CASE OF AMLODEPINE WHERE IT IS MODEST AND LESS VARIABLE.
• ALL CCBs ARE HIGHLY PROTEIN BOUND AND ALL ARE HIGH CLEARANCE DRUGS AND HAVE EXTENSIVE TISSUE DISTRIBUTION.
• ALL ARE UPTO 90% METABOLIZED IN LIVER AND EXCRETED IN URINE. SOME METABOLITES ARE ACTIVE.
• ELIMINATION t1/2 RANGES FROM 2 – 6 HRS, BUT THAT OF AMLODEPINE IS EXCEPTIONALLY LONG, FOLLOWED BY LACIDIPINE, NITRENDIPINE & FELODEPINE.
• ON CHRONIC ADMINISTRATION VERAPAMIL INHIBITS ITS OWN METABOLISM AND THE BIOAVAILABILITY GETS DOUBLED AND t ½ PROLONGED.
![Page 61: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/61.jpg)
ANTI-ANGINAL
• THERAPEUTIC USES OF CCBs:• THESE ARE SAFE IN ASTHMATICS AND
DIABETICS WHERE BETA BLOCKERS ARE CONTRAINDICATED.
• REBOUND INCREASE IN ANGINA AND B.P IS LESS MARKED WITH CCBs ON WITHDRAWAL AFTER CHRONIC USE AS IN THE CASE OF BETA BLOCKERS.
![Page 62: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/62.jpg)
ANTI-ANGINAL
• THE IMPORTANT THERAPEUTIC USES ARE:• 1. CLASSICAL & VARIANT ANGINA.• 2. MYOCARDIAL INFARCTION.• 3. HYPERTENSION.• 4. CARDIAC ARRHYTHMIAS.• 5. HYPEETROPHIC CARDIOMYOPATHY.• 6. MISC: PREMATURE LABOUR, MIGRAINE,
NOCTURNAL LEG CRAMPS, P.V.Ds
![Page 63: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/63.jpg)
ANTI-ANGINAL
• 1. ANGINA: ALL CCBs ARE EFFECTIVE IN REDUCING THE FREQUENCY & SECVEDRITY OF CLASSICAL AS WELL AS VARIANT ANGINA:
• REDUCE CARDIAC WORK BY DECREASING AFTERLOAD,
• INCREASE CORNARY BLOOD FLOW,• INCREASE EXERCIASE TOLERANCE.
![Page 64: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/64.jpg)
ANTI-ANGINAL
• SHORT ACTING AND RAPIDLY ACXTING DHPs LIKE NIFEDEPINE CAN AGGRAEVATE MYOCARDIAL ISCHEMIA DUE TO DECREASED CORONARY BLOOD FLOW SECONDARY TO A DECREASE IN MEAN ARTERIAL B.P., REFLEX TACHYCARDIA AND CORONARY STEAL .
• DILTIAZEM & VERAPAMIL UNLIKELY TO DO SO AS THEY DIRECTLY DECREASE CARDIAC OXYGEN DEMAND AND PRODUCE LESS MARKED SYMPATHETIC STIMULATION.
![Page 65: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/65.jpg)
ANTI-ANGINAL• MOREOVER, HIGH DOSE REGULAR SHORT ACTING
NIFEDEPINE FORMULATIONS ARE REPORTED TO INCREASE MORTALITY IN MI PATIENTS.
• THE SUDDEN RUSH OF SYMPATHETIC OVERACTIVITY PRODUCED BY EACH DOSE OF SUCH PREPARATIONS HAS BEEN HELD RESPONSIBLE FOR THIS DELETERIOUS EFFECT.
• THE SLOW AND LONG ACTING FORMULATIONS DO NOT HAVE THIS DISADVANTAGE.
• DILTIAZEM & VERAPAMIL REDUCE REINFARCTION & MORTALITY IN MI PATIENTS ALMOST COMPARABLE TO THAT OF BETA BLOCKERS PROVIDED THE PATIENTS HAVE UNCOMPROMISED LV-FUNCTION.
![Page 66: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/66.jpg)
ANTI-ANGINAL• IN VARIANT ANGINA THE CCBs AFFORD BENEFIT
MAINLY DUE TO THEIR ABILITY TO REVERSE CORONARY VASOSPASM, THOUGH DECREASE OXYGEN DEMAND ALSO HELPS.
• THESE ARE DEFINITELY ADD ON DRUGS TO NITRATES IN VARIANT ANGINA.
• 2. MYOCARDIAL INFARCTION: THE CONSENSUS IS AGAINST THE USE OF CCBs IN MI.
• NEVERTHELESS VERAPAMIL & DILTIAZEM MAY BE USED FOR SECONDARY PROPHYLAXIS IN THOSE PATIENTS WHERE BETA BLOCKERS ARE CONTRAINDICATED.
![Page 67: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/67.jpg)
ANTI-ANGINAL
• 3. HYPERTENSION: CCBs ARE NOW AMONGST THE FIRST LINE OF DRUGS FOR H.T.
• 4. CARDIAC ARRHYTHMIAS: • - VERAPAMIL & DILTIAZEM ARE HIGHLY EFFECTIVE
IN P.S.V.T. AND FOR CONTROLLING VENTRICULAR RATE IN SUPRAVENTRICULAR ARRHYTHMIAS.
• 5. HYPERTROPHIC CARDIOMYOPATHY: VERAPAMIL IS HIGHLY EFFECTIVE FOR ITS NEGATIVE INOTROPIC ACTION.
![Page 68: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/68.jpg)
ANTI-ANGINAL• INDIVIDUAL CCBs:• 1. VERAPAMIL: • ARTERIOLAR DILATOR,• SOME ALPHA BLOCKING ACTION,• DECREASES TPR BUT B.P IS ONLY MODESTLY LOWERED,• PRONOUNCED & DIRECT CARDIAC NEGATIVE INOTROPIC ACTION,• H.R IS REDUCED,• A.V CONDUCTION IS SLOWED,• C.O. IS MAINTAINED BY SOME REFLEX SYMPATHETIC STIMULATION AND
DECREASE IN AORTIC IMPEDENCE,• CORONARY FLOW IS INCREASED,• BUT CARDIAC CONTRACTILITY IS MARKEDLY IMPAIRED IN CHF PATIENTS
SO CONTRAINDICATED. • DOSE: 40 – 160 mg TDS.
![Page 69: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/69.jpg)
ANTI-ANGINAL• N, V, CONSTIPATION ARE MORE COMMON SIDE
EFFECTS BUT FLUSHING, HEADACHE AND ANKLE EDEMA ARE UNCOMMON.
• HYPOTENSION IS UNCOMMON.• TACHYCARDIA DOES NOT OCCUR.• CAN ACCENTUATE CONDUCTION DEFECTS, SO
CONTRAINDICATED IN 2ND AND 3RD DEGREE HEART BLOCKS.
• I.V. USE MAY CAUSE CARDIAC ARREST IN PATIENTS WITH SICK SINUS SYNDROME.
![Page 70: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/70.jpg)
ANTI-ANGINAL
• DRUG INTERACTIONS OF VERAPAMIL:• - PRODUCES ADDITIVE SINUS DEPRESSION,
CONDUCTION DEFECTS, ASYSTOLE WITH BETA BLOCKERS.
• DECCREASES DIGITALIS EXCRETION, INCREASES ITS PLASMA CONCENTRATION TO TOXIC LEVELS.
• IT SHOULD NOT BE USED WITH DIRECT MYOCARDIAL DEPRESSANTS DRUGS LIKE QUINIDINE AND DISOPYRAMIDE
![Page 71: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/71.jpg)
ANTI-ANGINAL• 2. DILTIAZEM:• LESS POTENT VASODILATOR THAN NIFEDEPINE &
VERAPAMIL.• MODEST DIRECT NEGATIVE INOTROPIC ACTION.• DIRECT DEPRESSANT ACTION ON S.A. & A.V. NODAL
CONDUCTION EQUAL TO VERAPAMIL.• USUAL DOSES CAUSE CONSISTENT FALL IN B.P WITHOUT
CHANGE IN HR OR BRADYCARDIA.• LARGE DOSES OR IV ADMINISTRATION DECREASES T.P.R.
MARKEDLY WITH REFLEX TACHYCARDIA.• DILATES CORONARIES.• DOSE: 30 – 60 mg TDS /QID.
![Page 72: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/72.jpg)
ANTI-ANGINAL
• ADVERSE EFFECTS OF DILTIAZEM:• LOW INCIDENCE OF SIDE EFFECTS SIMILAR TO
VERAPAMIL.• INCREASES PLASMA DIGOXIN LEVELS.• CONTRAINDICATED IN PATIENTS OF SICK-
SINUS, A.V.NODAL OR MYOCARDIAL DISEASES.• ONLY LOW DOSES CAN BE GIVEN TO PATIENTS
RECEIVING BETA BLOCKERS.
![Page 73: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/73.jpg)
ANTI-ANGINAL DRUGS• 3. NIFEDEPINE: • PROTOTYPE DIHYDROPYRIDINE CCB.• FAST & SHORTER ACTING.• VERY POTENT ARTERIOLAR DILATOR -> T.P.R DECREASES MARKEDLY ->
B.P FALLS ASSOCIATED WITH REFLEX TACHYCARDIA AND SYMPATHETIC OVERACTIVITY.
• HIGHER DOSES DIRECTLY DEPRESS THE HEART.• DOES NOT DEPRESS S.A OR A.V CONDUCTION.• REFLEX SYMPATHETIC STIMULATION PREDOMINATES -> TACHYCARDIA -
> INCREASED CONTRACTILITY, AND C.O. BECAUSE THERE IS NO DECREASE IN VENOUS RETURN WITH LOWERING OF AFTER LOAD.
• CORONARY BLOOD FLOW IS INCREASED. • IT HAS MILD NATRIURETIC ACTION BUT SIGNIFICANT DIURESIS DOES
NOT OCCUR.• DOSE: 5 – 20 mg. BD TO TDS, ORAL
![Page 74: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/74.jpg)
ANTI-ANGINAL DRUGS• ADVERSE EFFECTS OF NIFEDEPINE:• FREQUENT SIDE EFFECTS ARE:• - PALPITATION,• - FLUSHING,• - ANKLE EDEMA,• - HYPOTENSION,• - HEADACHE,• - DROWSINESS, AND• - NAUSEA.• THESE ARE DOSE RELATED CAN BE MINMISED BY LOW
STARTIN DOSES, FRACTIONATION OF DOSES OR USING RETARD PREPARATION.
![Page 75: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/75.jpg)
ANTI-ANGINAL DRUGS• OTHER SERIOUS SIDE EFFECTS ARE:• - PARADOXICAL AGGRAEVATION OF
ANGINA, • - HIGHER MORTALITY IN POST MI PATIENTS.• IT CAN BE SAFELY ADMINISTERED WITH BETA
BLOCKERS , DIGOXIN ETC.• IT CAN INCREASE URINE VOIDING DIFFICULTY IN
ELDERLY PATIENTS DUE ITS SMOOTH MM RELAXANT EFFECT ON URINARY BLADDER.
• IT DECREASES DIABETIC CONTROL BY INHIBITIN INSULIN RELEASE.
![Page 76: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/76.jpg)
ANTI-ANGINAL DRUGS
• 4. FELODEPINE:• GREATER VASCULAR SMOOTH MM
SELECTIVITY THAN NIFEDEPINE.• LARGER TISSUE DISTRIBUTION,• LONGER t ½ .• EXTENDED RELEASE PREPARATION SUITABLE
FOR ONCE DAILY DOSING.• DOSE: 5 – 10 mg OD TO BD.
![Page 77: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/77.jpg)
ANTI-ANGINAL DRUGS• 5. AMLODEPINE:• MOST DISTINCT DHP PHARMACOKINETICALLY.• COMPLETE BUT SLOW ORAL ABSORPTION.• PEAK IN 6 – 9 HRS., SO EARLY SIDE EFFECTS OF
VASODILATATION LIKE PALPITATION, FLUSHING, HEADACHE, POSTURAL DIZZINESS ARE LARGELY CIRCUMVENTED.
• HAS LESS VARIABLE FIRST PASS METABOLISM, AND CONSISTENT & HIGHER ORAL BIOAVAILABILITY.
• LARGE VOLUME DISTRIBUTION AND VERY LONG t ½ ,• DIURNAL FLUCTUATIONS IN BLOOD ARE MINIMAL & ACTION
EXTENDS TILL NEXT MORNING.• DOSE : 5 TO 10 mg OD.
![Page 78: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/78.jpg)
ANTI-ANGINAL DRUGS• 6. NITRENDIPINE:• 10 – 30% ORALLY BIOVAILABLE,• t ½ 4 – 12 HRS.• RELEASES NITRIC OXIDE FROM ENDOTHELIUM.• INHIBITS c-AMP –PHOSPHODIESTERASE, AN
ADDITIONAL MECHANISM OF VASODILATOR ACTION.• VENTRICULAR CONTRACTILITY & AV CONDUCTION ARE
NOT DEPRESSED.• USED FOR H.T AND ANGINA.• DOSE : 5 TO 20 mg OD.
![Page 79: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/79.jpg)
ANTI-ANGINAL DRUGS
• 7. LACIDIPINE:• HIGHLY VASOSELECTIVE.• ONCE DAILY DOSE• ATTAINS HIGHER CONCENTRATIONS IN
VASCULAR SMOOTH MM. MEMBRANE.• USED FOR HT ONLY.• DOSE: 4 mg OD.
![Page 80: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/80.jpg)
ANTI-ANGINAL DRUGS• 8. NIMODIPINE:• LIPID SOLUBLE, ENTERS BRAIN, HIGHLY
CEREBROSELECTIVE.• APPROVED FOR PREVENTION AND TREATMENT
OF NEUROLOGICAL DEFICIT DUE TO CEREBRAL VASOSPASM FOLLOWING S.A.H OR RUPTURED CONGENITAL INTRACRANIAL ANEURYSMS.
• SIDE EFFECTS ARE HEADACHE, FLUSHING, DIZINESS, PALPITATION AND NAUSEA.
• DOSE : 30 – 60 mg 4 – 6 HOURLY FOR THREE WEEKS FOLLOWING S.A.H.
![Page 81: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/81.jpg)
ANTI-ANGINAL DRUGS
• 9. LERCANIDIPINE:• SIMILAR TO NIFEDIPINE BUT LONGER ACTING,• PEAK IN 1.5 TO 3 HRS.• t½ IS 5 TO 10 HRS.• USED IN HT AND ANGINA.• DOSE : 10 TO 20 mg OD.
![Page 82: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/82.jpg)
ANTI-ANGINAL DRUGS
• 10. BENIDIPINE:• LONG ACTING DHP DUE TO ITS SLOW
DISSOCIATION FROM DHP RECEPTOR ON THE SMOOTH MM CELLS.
• USED FOR HT AND ANGINA.• DOSE: 4 TO 8 mg OD.
![Page 83: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/83.jpg)
ANTI-ANGINAL DRUGS
POTASSIUM CHANNEL OPENERS:• MINOXIDIL AND DIAZOXIDE ARE K+ CHANNEL
OPENERS WHICH HAVE BEEN USED SINCE LONG IN SEVERE HYPER TENSION AND HYPERTENSIVE EMERGENCIES.
• NEWER K+ CHANNEL OPENERS LIKE NICORANDIL, PINACIDIL, CROMAKALIM AND OTHERS HAVE BEEN DEVELOPED RECENTLY.
![Page 84: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/84.jpg)
ANTI-ANGINAL• SINCE INTRACELLULAR CONCENTRATION OF K+ IS MUCH HIGHER
(150mM) COMPARED TO EXTRA CELLULAR (4-5mM), K+ CHANNEL OPENING RESULTS IN OUTFLOW OF K+ IONS AND HYPERPLOARIZATION.
• THERE ARE MULTIPLE TYPES OF K+ CHANNELS:• - VOLTAGE DEPENDENT, • - Ca++ ACTIVATED,• - RECEPTOR OPERATED,• - ATP SENSITIVE, • - Na+ ACTIVATED AND• - CELL VOLUME SENSITIVE.• ALL OF WHICH SERVE DIVERSE FUNCTIONS AND EXHIBIT DIFFERENT
SENSITIVITIES TO DRUGS. AS SUCH K+ CHANNEL OPENERS EXHIBIT CONSIDERABLE DIVERSITY IN ACTIONS.
• THE MOST PROMINENT ACTION OF K+ CHANNEL OPENERS IS SMOOTH MUSCLE RELAXATION BOTH VASCULAR AS WELL AS VISCERAL.
![Page 85: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/85.jpg)
ANTI-ANGINAL
• THE POTENTIAL CLINICAL USES OF THESE DRUGS ARE BASED PRIMARILY ON THIS PROPERTY OF K+ CHANNEL OPENERS.
• DIAZPXIDE AND SOME OTHER K+ CHANNEL OPENERS REDUCE INSULIN SECRETION, WHILE THE SULPHONYL UREA O.H.As CAUSE HYPOGLYCEMIA BY BLOCKING K+ CHANNELS IN PANCREATIUC BETA CELLS AND PROMOTING INSULIN RELEASE.
![Page 86: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/86.jpg)
ANTI-ANGINALPOTENTIAL THERAPEUTIC USES OF K+ CHANNEL OPENERS AREFOLLOWING:• 1. ANGINA PECTORIS,• 2. HYPERTENSION,• 3. CONGESTIVE HEART FAILURE,• 4. MYOCARDIAL SALVAGE IN M.I.,• 5. ANTIHYPOGLYCEMIC IN INSULINOMA,• 6. ALOPECIA,• 7. BRONCHIAL ASTHMA,• 8. URINARY URGE INCONTRINENCE,• 9. P.V.D. ( RENAUD’S DISEASE, CEREBROVASCULAR),• 10. ERECTILE DYSFUNCTION, AND• 11. PREMATURE LABOUR.
![Page 87: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/87.jpg)
ANTI-ANGINALNICORANDIL:• THIS NOVEL ANTIANGINAL DRUG ACTIVATES ATP SENSITIVE
K+ CHANNELS – > HYPERPOLARIZING VASCULAR SMOOTH MUSCLE .
• LIKE NITRATES IT ALSO ACTS AS A NO DONOR –> RELAXES BLOOD VESSELS BY INCREASING C-GMP.
• ARTERIAL DILATATION IS COUPLED WITH VENODILATATION.
• CORONARY FLOW IS INCREASED BY THE DILATATION OF BOTH EPICARDIAL CONDUCTING VESSELS AND DEEPER RESISTANCE VESSELS.
• NO SIGNIFICANT CARDIAC EFFECTS ON CONTRACTILITY AND CONDUCTION HAVE BEEN NOTED.
![Page 88: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/88.jpg)
ANTI-ANGINAL• BENEFICIAL EFFECTS ON ANGINA FREQUENCY AND EXERCISE
TOLERANCE COMPARABLE TO NITRATES, ΒETA BLOCKERS AND C.C.Bs HAVE BEEN OBTAINED IN STABLE AS WELL AS VASOSPASTIC ANGINA.
• SIDE EFFECTS ARE:• FLUSHING,• PALPITATION, • WEAKNESS, • HEADACHE, • DIZZINESS, • MOUTH ULCERS,• NAUSEA AND • VOMITING.• DOSE: 5 TO 20O mg BD.
![Page 89: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/89.jpg)
ANTI-ANGINAL• MITOCHONDRIAL K+ATP CHANNEL OPENING BY
NICORANDIL IS BELIEVED TO EXERT MYOCARDIAL PROTECTION BY A PROCES CALLED ISCHEMIC PRECONDITIONINGWHICH APPEARS TO REDUCE MYOCARDIAL STUNNING, ARRHYTHMIAS AND INFARCT SIZE WHEN A CORONARY ARTERY IS SUDDENLY BLOCKED.
• MYOCARDIAL RECOVERY FROM ISCHEMIC DAMAGE AFTER MI AS MEASURED BY LEFT VENTRICULAR WAKLL MOTION IS ALSO IMPROVED BY NICORANDIL.
![Page 90: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/90.jpg)
ANTI-ANGINALMISCELLANEOUS ANTI-ANGINAL DRUGS:1. DIPYRIDAMOLE:• - IT IS A POWERFUL CORONARY DILATOR, AND INCREASES TOTAL
CORONARY BLOOD FLOW BY PREVENTING UPTAKE & DEGRADATION OF ADENOSINE WHICH IS A LOCAL MEDIATOR INVOLVED IN AUTO-REGULATION OF CORONARY FLOW IN RESPONSE TO ISCHEMIA.
• - IT DILATES RESISTANCE VESSELS AND ABOLISHES AUTOREGULATION AND HAS NO EFFECT ON LARGER CONDUCTING CORONARY VESSELS. –-- CARDIAC WORK IS NOT DECREASED BECAUSE VENOUS RETURN IS NOT REDUCED.
• - B.P. IS MINIMALLY ALTERED.• - IT DOES NOT AFFORD SYMPTOMATIC RELIEF OR AVERT E.C.G.
CHANGES OF ANGINA.
![Page 91: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/91.jpg)
ANTI-ANGINAL
• THE PHARMACOLOGICAL SUCCESS BUT THERAPEUTIC FAILURE OF DIPYRIDAMOLE HAS BEEN EXPLAINED ON THE BASIS OF ‘CORONARY STEAL’ PHENOMENON.
• BY DILATING RESISTANCE VESSELS IN NON-ISCHAEMIC ZONE AS WELL, IT DIVERTS THE ALREADY REDUCED BLOOD FLOW AWAY FROM ISCHAEMIC ZONE.
![Page 92: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/92.jpg)
ANTI-ANGINAL
• - DIPYRIDAMOLE INHIBITS PLATELET AGGREGATION.
• - THOUGH NOT USEFUL AS AN ANTIANGINAL DRUGS IT IS BEING EMPLOYED FOR PROPHYLAXIS OF CORONARY AND CEREBRAL THROMBOSIS IN POST MI AND POST-STROKE PATIENTS, AS WELL AS TO PREVENT THROMBOSIS IN PATIENTS WITH PROSTHETIC HEART VALVES.
• DOSE: 25 – 100 mg. TDS.
![Page 93: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/93.jpg)
ANTI-ANGINAL2. TRIMETAZIDINE:• THIS NOVEL ANTIANGINAL DRUG ACTS BY NON-
HAEMODYNAMIC MECHANISMS. • THERE IS NO EFFECT ON DETERMINANTS OF
MYOCARDIAL O2 - CONSUMPTION, SUCH AS H.R. AND B.P., BOTH AT REST AS WELL AS DURING EXERCISE, BUT ANGINA FREQUENCY IS REDUCED AND EXERCISE CAPACITY IS INCREASED.
• IN NITRATE/ Β BLOCKER /CCB, ADDITION OF TRIMETAZIDINE FURTHER REDUCES ANGINAL ATTACKS AND INCREASES EXERCISE DURATION.
![Page 94: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/94.jpg)
ANTI-ANGINAL• THE MECHANISM OF ACTION OF TRIMETAZIDINE IS NOT
KNOWN, BUT IT MAY IMPROVE CELLULAR TOLERANCE TO ISCHAEMIA BY FOLLOWING MECHANISMS:
• - INHIBITING MITOCHONDRIAL LONG CHAIN 3-KETOACYL-CoA-THIOLASE (LC3-KAT), A KEY ENZYME IN FATTY ACID OXIDATION -> THERBY REDUCINGFATTY ACID METABOLISM & INCREASING GLUCOSE METABOLISM IN MYOCARDIUM. ISCHEMIC MYOCARDIUM SHIFTS TO UTILIZING FATTY ACIDS AS SUNSTRATE -> INCREASING OXYGEN REQUIREMENT FOR THE SAME AMOUNT OF ATP GENERATED. SINCE OXIDATION OF FATTY ACIDS REQUIRESC MORE OXYGEN SHIFT BACK OF SUBSTRATE TO GLUCOSE WOULD REDUCE OXYGEN DEMAND. IT HAS BEEN LABELLED AS PFOX ( FATTY ACID OXIDATION PATHWAY) INHIBITOR.
![Page 95: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/95.jpg)
ANTI-ANGINAL• - LIMITING INTRACELLULAR ACIDOSIS AND
Na+, Ca+ ACCUMULATION DURING ISCHEMIA,• - PROTECTING AGAINST O+ FREE RADICAL
INDUCED MEMBRANE DAMAGE. • TRIMETAZIDINE IS ABSORBED ORALLY, PARTLY
METABOLIZED AND LARGELY EXCRETED UNCHANGED IN URINE.
• TRIMETAZIDINE IS GENERALLY WELL TOLERATED; SIDE EFFECTS ARE: GASTRIC BURNING, DIZZINESS, FATIGUE AND MUSCLE CRAMPS AND REVERSIBLE PARKINSONISM.
![Page 96: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/96.jpg)
ANTI-ANGINAL• STATUS OF TRIMETAZIDINE IN ISCHAEMIC HEART
DISEASE AND LONG-TERM SURVIVAL BENEFITS ARE NOT YET DEFINED. IT IS MOSTLY USED AS ADDITIONAL MEDICATION TO CONVENTIONAL THERAPY IN ANGINA AND POST – MI PATIENTS.
• OTHER USES OF TRIMETAZIDINE ARE:• - VISUAL DISTURBANCES,• - TINNITUS,• - MENIERE’S DISEASE,• - DIZZINESS
![Page 97: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/97.jpg)
ANTI-ANGINAL• 3. RANOLAZINE:• NEW CONGENER LC3-KAT-INHIBITOR.• USED FOR CHRONIC ANGINA NOT RESPONDING TO OTHER DRUGS.• IT SPARES FATTY ACID OXIDATION & SHIFTS ATP PRODUCTION TO MORE OXYGEN
EFFICIENT CARBOHYDRATE OXIDATION.• ALSO INHIBITS LATE I-Na CURRENT IN MYOCARDIUM WHICH INDIRECTLY
FACILITATE Ca++ ENTRY. REDUCTION IN Ca++ OVERLOAD IN THE MYOCARDIUM DURIN ISCHEMIA MAY PLAY AN IMPORTANT ROLE IN THE CARDIOPROTECTION ACTION OF RANOLAZINE.. CAN BE USED AS MONOTHERAPY OR ADD ON THERAPY IN ANGINA.
• SLOW ORAL ABSORPTION.• PEAK IN 4 TO 6 HRS.• ORAL BIOAVAILABILITY 30 TO 40%. METABOLISED IN LIVER, EXCRETED IN URINE,
t ½ 7 HRS.• ADDED SIDE EFFECTS ARE POSTURAL HYPOTENSION, PROLONGATION OF QT-
INTERVAL WITH RISK OF TORSIDES DE POINTES. • DOSE : 0.5 TO 1.0 gm. BD.
![Page 98: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/98.jpg)
ANTI-ANGINAL
• 4. OXYPHEDRINE:• IT IMPROVES MYOCARDIAL METABOLISM SO
THAT HEART CAN SUSTAIN HYPOXIA BETTER.• IT CAN DIMINISH OR ALTER TASTE
SENSATION.• DOSE : 8 TO 24 mg TDS
![Page 99: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/99.jpg)
ANTI-ANGINAL
DRUG THERAPY IN MYOCARDIAL INFARCTION :• MYOCARDIAL INFARCTION (MI) IS ISCHAEMIC
NECROSIS OF A PORTION OF THE MYOCARDIUM DUE TO SUDDEN OCCLUSION OF A BRANCH OF CORONARY ARTERY. AN ACUTE THROMBUS AT THE SITE OF ATHEROSCLEROTIC OBSTRUCTION IS THE USUAL CASE.
![Page 100: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/100.jpg)
ANTI-ANGINAL
• ABOUT ¼ PATIENTS DIE BEFORE THERAPY CAN BE INSTITUTED. THE REMAINING ARE BEST TREATED IN SPECIALIZED CORONARY CARE UNITY WITH CONTINUOUS MONITORING OF THE HAEMODYNAMIC PARAMETERS AND ECG GUIDE THE SELECTION OF DRUGS AND DOSAGE. THOSE WHO RECEIVE SUCH FACILITY CAN BE GREATLY BENEFITED BY DRUG THERAPY, WHICH ACCORDING TO INDIVIDUAL NEEDS IS DIRECTED TO FOLLOWING AIMS.
![Page 101: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/101.jpg)
ANTI-ANGINAL1. PAIN, ANXIETY AND APPREHENSION:- OPIOID
ANALGESICS (MORPHINE/PETHIDINE), DIAZEPAM.2. OXYGENATION:- BY O2 INHALATION AND
ASSISTED RESPIRATION, IF NEEDED. 3. MAINTENANCE OF BLOOD VOLUME, TISSUE,
PERFUSION AND MICROCIRCULATION:- SLOW I.V. INFUSION OF SALINE/ LOW MOLECULAR WEIGH DEXTRAN (AVOID VOLUME OVERLOAD).
4. CORRECTION OF ACIDOSIS:- DUE TO LACTIC ACID PRODUCTION – SOD. BICARBONATE BY I.V. INFUSION.
![Page 102: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/102.jpg)
ANTI-ANGINAL
5.PREVENTION AND TREATMENT OF ARRHYTHMIAS:- PROPHYLACTIC INFUSION OF Β BLOCKER AS SOON AS ATHE MI PATIENT IS SEEN AND ITS CONTINUATION FOR A FEW DAYS HAS BEEN SHOWN TO REDUCE THE INCIDENCE OF ARRHYTHMIAS AND MORTALITY. Β BLOCKERS USED EARLY IN EVOLVING MI CAN REDUCE THE INFARCT SIZE (MYOCARDIAL SALVAGE) AND SUBSEQUENT COMPLICATIONS.
![Page 103: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/103.jpg)
ANTI-ANGINAL
• TACHYARRHYTHMIAS MAY BE TREATED WITH LIGNOCAINE, PROCAINAMIDE OR OTHER ANTIARRHYTHMICS. ROUTINE PROPHYLACTIC LIGNOCAINE INFUSION IS NOT RECOMMENDED NOW. BRADYCARDIA AND HEART BLOCK MAY BE MANAGED WITH ATROPINE OR ELECTRICAL PACING.
![Page 104: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/104.jpg)
ANTI-ANGINAL
6.PUMP FAILURE:- THE OBJECTIVE IS TO INCREASE C.O. AND/OR DECREASE FILLING PRESSURE WITHOUT UNDULY INCREASING CARDIAC WORK OR REDUCING BP. DRUGS USED FOR THIS PURPOSE ARE:
• FUROSEMIDE:- INDICATED IF PULMONARY WEDGE PRESSURE IS > 20MM HG. IT DECREASES CARDIAC PRELOAD..
![Page 105: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/105.jpg)
ANTI-ANGINAL• VASODILATORS:- ARTERIOLAR, VENOUS OR
COMBINED DILATOR IS SELECTED ACCORDING TO THE MONITORED HAEMODYNAMIC PARAMETERS. DRUGS LIKE GTN (I.V.), CAPTOPRIL, OR NITROPRUSSIDE HAVE BEEN MAINLY USED. INFUSED EARLY GTN MAY IN ADDITION LIMIT INFARCT SIZE AND REDUCE MORTALITY
• INOTROPIC AGENTS:- DOPAMINE OR DOBUTAMINE MAY BE NEEDED T AUGMENT THE PUMPING ACTION OF HEART AND TIDE OVER CRISIS.
![Page 106: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/106.jpg)
ANTI-ANGINAL DRUGS7. PREVENTION OF THROMBUS EXTENSION,
EMBOLISM, VENOUS THROMBOSIS:- HEPARIN FOLLOWED BY ORAL ANTICOAGULANTS. HOWEVER, VALUE IS DISPUTED. ANY BENEFIT IS SHORT TERM; ANTICOAGULANTS ARE NOT PRESCRIBED ON LONG-TERM BASIS NOW.
8. THROMBOLYSIS:- FIBRINOLYTIC AGENTS, I.E., PLASMINOGEN ACTIVATORS- STREPTOKINASE/UROKINASE/ALTEPLASE TO ACHIEVE REPERFUSION OF THE INFRACTED AREA.
![Page 107: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/107.jpg)
ANTI-ANGINAL DRUGS
9. PREVENTION OF REMODELING AND SUBSEQUENT CHF:- ACE INHIBITORS HAVE PROVEN EFFICACY AND AFFORD LONG TERM SURVIVAL BENEFIT.
![Page 108: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/108.jpg)
ANTI-ANGINAL DRUGS
10. PREVENTION OF FUTURE ATTACKS:• PLATELET FUNCTION INHIBITORS –ASPIRIN GIVEN
ON LONG-TERM BASIS IS ROUTINELY PRESCRIBED.• Β BLOCKERS- REDUCE RISK OF REINFARCTION,
CHF AND MORTALITY. ALL PATIENTS NOT HAVING ANY CONTRAINDICATION ARE PUT ON A Β BLOCKER FOR AT LEAST 2 YEARS.
• CONTROL OF HYPERLIPIDAEMIA DIETARY SUBSTITUTION WITH UNSATURATED FAST, HYPOLIPIDEMIC DRUGS.
![Page 109: Anti Anginal Drugs](https://reader033.vdocuments.us/reader033/viewer/2022061123/5475a400b4af9f72088b464e/html5/thumbnails/109.jpg)
ANTI-ANGINAL DRUGS
• THANK YOU !